重复给予肾上腺素及给药时机对目击院外心脏骤停患者的影响
该研究利用日本2010至2012年全国Utstein风格数据,回顾性纳入11876例心源性且目击的院外心脏骤停患者,按肾上腺素给药次数分为单次、两次和三次及以上,并按呼叫至首次给药时间分为早期组(5-20分钟)、中间组(21-26分钟)和晚期组(27-60分钟)。主要终点为心脏骤停后1个月CPC 1-2。单次、两次、三次及以上给药组CPC 1-2达标率分别为4.8%、2.4%和1.7%。在早期给药组中,所有给药次数亚组的CPC 1-2达标率均显著更高;在单次和三次及以上给药亚组中,中间给药组CPC 1-2也显著高于晚期组。结论认为,在目击心源性院外心脏骤停中,若在紧急呼叫后20分钟内给予肾上腺素,重复给药可改善CPC 1-2结局。
要点
- 目击心源性院外心脏骤停患者中,单次给药组1个月CPC 1-2达标率为4.8%,两次组为2.4%,三次及以上组为1.7%。
- 早期给药组(呼叫后5-20分钟)在单次、两次、三次及以上给药亚组中CPC 1-2均显著高于晚期组,校正比值比分别为9.26、7.57、4.07。
- 单次给药亚组中,中间给药组(21-26分钟)CPC 1-2显著高于晚期组(校正比值比3.54,95%CI 2.04-6.39)。
- 三次及以上给药亚组中,中间给药组CPC 1-2也显著高于晚期组(校正比值比3.02,95%CI 1.16-9.43)。
- 在紧急呼叫后20分钟内给予肾上腺素时,重复给药与更好的1个月脑功能结局相关。
适用人群与场景
- 日本2010至2012年全国范围内、心源性且目击的院外心脏骤停患者,共11876例。
诊断标准与关键阈值
- 脑功能结局采用脑功能分级(CPC)评估,主要终点为心脏骤停后1个月CPC 1-2。
- 按肾上腺素给药次数分为单次、两次和三次及以上三组。
- 按紧急呼叫至首次肾上腺素给药时间分为早期给药组(5-20分钟)、中间给药组(21-26分钟)和晚期给药组(27-60分钟)。
研究设计与关键结果
- 研究类型为全国性、回顾性、基于人群的观察性研究,使用Utstein风格数据,纳入11876例心源性且目击的院外心脏骤停患者。
- 1个月CPC 1-2达标率:单次给药组4.8%,两次给药组2.4%,三次及以上给药组1.7%。
- 单次给药组中,中间给药组CPC 1-2显著高于晚期组(校正比值比3.54,95%CI 2.04-6.39)。
- 三次及以上给药组中,中间给药组CPC 1-2显著高于晚期组(校正比值比3.02,95%CI 1.16-9.43)。
- 早期给药组在单次、两次、三次及以上给药亚组中CPC 1-2均显著高于晚期组,校正比值比分别为9.26(95%CI 5.44-16.59)、7.57(95%CI 3.39-19.60)、4.07(95%CI 1.59-12.69)。
证据类型、等级与局限
- 证据类型:全国性、回顾性、基于人群的观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在目击心源性院外心脏骤停中,若在紧急呼叫后20分钟内给予肾上腺素,重复给药可改善CPC 1-2结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Repeated administration of epinephrine is associated with unfavorable cerebral outcome after out-of-hospital cardiac arrests (OHCA), but the timing of epinephrine administration has not been considered.
AIM: The aim of the study was to analyze the effects of repeated epinephrine administration after OHCA on favorable cerebral function coded by cerebral performance categories (CPC 1-2).
METHODS: A nationwide, retrospective, population-based observational study was conducted by using Utstein-style data between 2010 and 2012 in Japan. The total of 11,876 cardiogenic and witnessed OHCA were stratified into 3 categories by the number of times epinephrine was administered (single, double, and three or more). In addition, the time elapsed between the emergency call and the initial epinephrine administration was divided into 3 time intervals (5 to 20min for the early administration group [EAG], 21 to 26min for the intermediate administration group [IAG], and 27 to 60min for the late administration group [LAG]). The primary endpoint was CPC 1-2 at 1month after cardiac arrest. A multivariable logistic regression was used for analysis.
RESULTS: Achievement of CPC 1-2 at 1month was 4.8% for single, 2.4% for double, and 1.7% for three or more administered doses. For single and three or more administrations, CPC 1-2 was significantly higher in the IAG than in the LAG (adjusted odds ratio [AOR], 3.54, 3.02; 95% confidence interval [CI], 2.04-6.39, 1.16-9.43, for single and three or more administrations, respectively). The EAG showed significantly higher achievement of CPC 1-2 in all the epinephrine administration groups (AOR, 9.26, 7.57, 4.07; 95% CI, 5.44-16.59, 3.39-19.60, 1.59-12.69, for single, double, and three or more administrations, respectively).
CONCLUSION: Repeated epinephrine administration improved CPC 1-2 outcome when epinephrine was administrated within 20min after an emergency call for witnessed cardiogenic OHCA.
参考来源
- Sagisaka R, Tanaka H, Takyu H, et al. Effects of repeated epinephrine administration and administer timing on witnessed out-of-hospital cardiac arrest patients. Am J Emerg Med. 2017. PMID: 28473275. doi:10.1016/j.ajem.2017.04.052
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。